Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Outset Medical, Inc.OM · Entity 7026 | EVP Operations R&D & Service | May 15, 2026 | May 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Outset Medical, Inc.
Report date May 15, 2026 · Filed May 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 38,393 |
Reported balance
After 2026-05-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-15 · Sale · Disposed 1,582 · Balance 38,393 F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 4,277 shares of Common Stock underlying RSUs granted to the reporting person on July 24, 2023, January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2: This balance reflects a correction to the number of shares of Common Stock sold by the reporting person to satisfy tax withholding obligations as previously reported on a Form 4 filed on February 19, 2026. Due to an administrative error, the prior Form 4 reported the sale of 1,817 shares instead of the correct number, 1,830 shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 4,277 shares of Common Stock underlying RSUs granted to the reporting person on July 24, 2023, January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2: This balance reflects a correction to the number of shares of Common Stock sold by the reporting person to satisfy tax withholding obligations as previously reported on a Form 4 filed on February 19, 2026. Due to an administrative error, the prior Form 4 reported the sale of 1,817 shares instead of the correct number, 1,830 shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2026 Filed May 20, 2026 01:08 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,582 | $3.70 | $5,853.40 |
DisclosureSEC source: 0001484612-26-000026 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · EVP Operations R&D & Service 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,393 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 4,277 shares of Common Stock underlying RSUs granted to the reporting person on July 24, 2023, January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: This balance reflects a correction to the number of shares of Common Stock sold by the reporting person to satisfy tax withholding obligations as previously reported on a Form 4 filed on February 19, 2026. Due to an administrative error, the prior Form 4 reported the sale of 1,817 shares instead of the correct number, 1,830 shares. Read SEC document |
| February 17, 2026 Filed Feb 20, 2026 01:56 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,817 | $3.35 | $6,086.95 |
DisclosureSEC source: 0001983815-26-000004 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · EVP Operations R&D & Service 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,988 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 4,384 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, July 24, 2023, January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 21, 2026 Filed Jan 22, 2026 00:07 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 980 | $4.98 | $4,880.40 |
DisclosureSEC source: 0001484612-26-000018 · edgardoc.xml · nonDerivative · entry 2 Nash Marc · CIK 0001983815 · EVP Operations R&D & Service 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,805 F1 · shares: Required number of shares sold by the reporting person to cover partial tax withholding obligations in connection with the vesting of an aggregate of 14,839 shares of Common Stock underlying RSUs granted to the reporting person on June 10, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 20, 2026 Filed Jan 22, 2026 00:07 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 5,375 | $5.12 | $27,520.00 |
DisclosureSEC source: 0001484612-26-000018 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · EVP Operations R&D & Service 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,785 F1 · shares: Required number of shares sold by the reporting person to cover partial tax withholding obligations in connection with the vesting of an aggregate of 14,839 shares of Common Stock underlying RSUs granted to the reporting person on June 10, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 07, 2026 Filed Jan 8, 2026 22:10 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 108 | $4.27 | $461.16 |
DisclosureSEC source: 0001484612-26-000006 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · EVP Operations R&D & Service 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,160 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 289 shares of Common Stock underlying PSUs (i) which were, as previously reported, originally earned based on the achievement of applicable performance criteria as of December 31, 2024 or January 6, 2025, as applicable, as certified by the Compensation Committee of the Issuer's Board of Directors on January 17, 2025 and (ii) vested and were released on January 6, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| November 17, 2025 Filed Nov 18, 2025 21:33 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 247 | $4.60 | $1,136.20 |
DisclosureSEC source: 0001484612-25-000079 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · EVP Operations R&D & Service 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,268 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 674 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2023, July 24, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| August 25, 2025 Filed Aug 25, 2025 23:59 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 5,617 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-25-000073 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · EVP, R&D, Operations and Serv. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,515 F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on August 25, 2025. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on August 15, 2026, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| August 15, 2025 Filed Aug 18, 2025 20:01 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 243 | $12.88 | $3,129.84 |
DisclosureSEC source: 0001484612-25-000071 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,898 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 673 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2023, July 24, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 21:34 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 29,676 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-25-000062 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,141 F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on June 10, 2025. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 50% on January 17, 2026, and the remaining 50% shall vest in equal installments over the course of the following year on a quarterly basis on February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| May 15, 2025 Filed May 16, 2025 21:22 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 252 | $17.82 | $4,490.64 |
DisclosureSEC source: 0001484612-25-000047 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,465 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 673 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2023, July 24, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: These numbers have been adjusted to reflect the 1-for-15 reverse stock split the Issuer effected on March 20, 2025 (the "Reverse Stock Split"). Includes 333 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2024 to February 28, 2025. This transaction is exempt from Rule 16b-3(c). Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 21:29 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 4,204 | $0.90 | $3,783.60 |
DisclosureSEC source: 0001484612-25-000032 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,764 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 11,581 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, March 15, 2021, March 15, 2022, March 15, 2023, July 24, 2023, and January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 21, 2025 Filed Jan 22, 2025 23:04 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 304 | $0.80 | $243.20 |
DisclosureSEC source: 0001484612-25-000024 · edgardoc.xml · nonDerivative · entry 6 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,968 F6 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 50% of the PSUs, described in footnote (2) above, on January 17, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 21, 2025 Filed Jan 22, 2025 23:04 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 971 | $0.80 | $776.80 |
DisclosureSEC source: 0001484612-25-000024 · edgardoc.xml · nonDerivative · entry 5 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,272 F5 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 50% of the PSUs, described in footnote (1) above, on January 17, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 21, 2025 Filed Jan 22, 2025 23:04 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 21,590 | $0.80 | $17,272.00 |
DisclosureSEC source: 0001484612-25-000024 · edgardoc.xml · nonDerivative · entry 4 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,243 F4 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 50,000 shares of Common Stock underlying PRSUs which (i) represent 50% of the target shares underlying the original award (granted on January 12, 2024, as previously reported), which were earned based on performance as of December 31, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors, and (ii) vested and were released on January 17, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 21, 2025 Filed Jan 22, 2025 23:04 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 356 | $0.80 | $284.80 |
DisclosureSEC source: 0001484612-25-000024 · edgardoc.xml · nonDerivative · entry 3 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 227,833 F3 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 824 shares of Common Stock underlying PSUs which (i) were, as previously reported, granted to the reporting person on March 15, 2022, (ii) were earned as of January 26, 2024 as certified by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria, and (iii) vested and were released on January 17, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 17, 2025 Filed Jan 22, 2025 23:04 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 1,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-25-000024 · edgardoc.xml · nonDerivative · entry 2 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228,189 F2 · shares: On July 24, 2023, the reporting person was granted performance-based restricted stock units (PSUs) subject to the satisfaction of specified performance criteria as of December 31, 2024. The reported amount represents the number of PSUs earned by the reporting person on January 17, 2025, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria. Each PSU represents a contingent right to receive a share of common stock. These PSUs vested 50% on January 17, 2025, and the remaining 50% shall vest on December 31, 2025, subject to the reporting person's continuous service through the vesting period. Read SEC document |
| January 17, 2025 Filed Jan 22, 2025 23:04 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 4,494 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-25-000024 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 226,785 F1 · shares: On March 15, 2023, the reporting person was granted performance-based restricted stock units (PSUs) subject to the satisfaction of specified performance criteria as of December 31, 2024. The reported amount represents the number of PSUs earned by the reporting person on January 17, 2025, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria. Each PSU represents a contingent right to receive a share of common stock. These PSUs vested 50% on January 17, 2025, and the remaining 50% shall vest on December 31, 2025, subject to the reporting person's continuous service through the vesting period. Read SEC document |
| January 13, 2025 Filed Jan 13, 2025 23:36 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 15,011 | $0.81 | $12,158.91 |
DisclosureSEC source: 0001484612-25-000015 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,291 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 31,996 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 07, 2025 Filed Jan 8, 2025 00:28 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 720 | $1.29 | $928.80 |
DisclosureSEC source: 0001484612-25-000007 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 237,302 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 1,581 shares of Common Stock underlying PSUs which (i) were, as previously reported, originally earned by the reporting person on January 12, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria, and (ii) vested and were released on January 6, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| November 15, 2024 Filed Nov 18, 2024 22:48 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,375 | $0.80 | $1,100.00 |
DisclosureSEC source: 0001484612-24-000073 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238,022 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 3,584 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, March 15, 2021, March 15, 2022, March 15, 2023, and July 24, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 00:01 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,293 | $0.84 | $1,086.12 |
DisclosureSEC source: 0001484612-24-000065 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239,397 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 3,584 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, March 15, 2021, March 15, 2022, March 15, 2023, and July 24, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| July 24, 2024 Filed Jul 24, 2024 23:08 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 723 | $4.02 | $2,906.46 |
DisclosureSEC source: 0000905148-24-001998 · form4.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 240,690 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 1,999 shares of Common Stock underlying RSUs granted to the reporting person on July 24, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| May 16, 2024 Filed May 17, 2024 21:38 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,097 | $3.53 | $3,872.41 |
DisclosureSEC source: 0001484612-24-000048 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 241,413 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 3,084 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, March 15, 2021, March 15, 2022, and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| March 15, 2024 Filed Mar 15, 2024 22:40 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 2,391 | $2.13 | $5,092.83 |
DisclosureSEC source: 0001484612-24-000039 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 242,510 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 6,399 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Includes 1,801 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2023 to February 29, 2024. This transaction is exempt from Rule 16b-3(c). Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 22:27 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 617 | $3.57 | $2,202.69 |
DisclosureSEC source: 0001484612-24-000029 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 243,100 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 1,484 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, March 15, 2021 and March 15, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 01:01 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 678 | $429.00 | $290,862.00 |
DisclosureSEC source: 0001484612-24-000016 · edgardoc.xml · nonDerivative · entry 4 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 243,717 F5 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of PSUs on January 12, 2024 described in footnote (4) above. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 12, 2024 Filed Jan 18, 2024 01:01 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 3,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-24-000016 · edgardoc.xml · nonDerivative · entry 3 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 244,395 F4 · shares: On January 26, 2022, the reporting person was granted performance-based restricted stock units ("PSUs") subject to the satisfaction of specified performance criteria as of December 31, 2023. The reported amount represents the number of PSUs earned by the reporting person on January 12, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria. Each PSU represents a contingent right to receive one share of common stock. These PSUs vested 50% on January 12, 2024, and the remaining 50% shall vest on December 31, 2024, subject to the reporting person's continuous service through the vesting date. Read SEC document |
| January 12, 2024 Filed Jan 18, 2024 01:01 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-24-000016 · edgardoc.xml · nonDerivative · entry 2 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 241,233 F3 · shares: Represents performance-based restricted stock units ("PSUs") granted to the reporting person on January 12, 2024, that vest over a three year period based on the Issuer's common stock achieving specified prices per share, if not earlier vested upon satisfaction of specified performance criteria, subject to the reporting person's continuous service through the applicable vesting date. Each PSU represents a contingent right to receive one share of common stock. Read SEC document |
| January 12, 2024 Filed Jan 18, 2024 01:01 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 96,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-24-000016 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,233 F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on January 12, 2024. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 12, 2025, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date. F2 · balance_after: This reflects the correct starting balance of directly owned shares which was incorrectly reported due to an administrative error in the original Form 3 filed on July 24, 2023. Read SEC document |
| November 16, 2023 Filed Nov 17, 2023 21:15 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 562 | $4.76 | $2,675.12 |
DisclosureSEC source: 0001484612-23-000087 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,757 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 1,484 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, March 15, 2021, and March 15, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Includes 321 share of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of March 1, 2023 to August 31, 2023. This transaction is exempt from Rule 16b-3(c). Read SEC document |
| August 16, 2023 Filed Aug 17, 2023 20:34 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 535 | $15.10 | $8,078.50 |
DisclosureSEC source: 0001484612-23-000069 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · SVP Operations and R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,998 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 1,485 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, March 15, 2021, and March 15, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees. Read SEC document |
| July 24, 2023 Filed Jul 24, 2023 22:13 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 338 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-23-000056 · edgardoc.xml · nonDerivative · entry 2 Nash Marc · CIK 0001983815 · VP Manufacturing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,533 F2 · shares: Represents a portion of stock units granted to the reporting person on July 24, 2023 that will vest on December 31, 2025, subject only to the reporting person's continuous service through the vesting date. Each stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| July 24, 2023 Filed Jul 24, 2023 22:13 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-23-000056 · edgardoc.xml · nonDerivative · entry 1 Nash Marc · CIK 0001983815 · VP Manufacturing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,195 F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on July 24, 2023. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on July 24, 2024, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.